MMP-13-IN-1

Cat. No.: HY-154868: FAQs
Data Sheet Handling Instructions

Molarity Calculator

MMP-13-IN-1 is a potent and selective inhibitor of MMP-13 with a IC₅₀ value of 16 nM. MMP-13-in-1 can be used for atherosclerosis research.

For research use only. We do not sell to patients.

MMP-13-IN-1 Chemical Structure

CAS No. : 2925249-49-4

Size		Stock
MOQ		Minimum order quantity
50 mg		Get quote
100 mg		Get quote
250 mg		Get quote
Other size		Get quote

Synthetic products have potential research and development risk.

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Featured Recommendations

•Related Small Molecules:

•Related Proteins:

View All MMP Isoform Specific Products:

View All Isoforms

MMP-1 MMP-2 MMP-3 MMP-8 MMP-9 MMP-13 MMP-14 MMP-17 ADAM10 ADAM17 MMP-7 MMP-12 MMP-10 MMP ADAM8

Biological Activity
Purity & Documentation
References
Customer Review

Description

MMP-13-IN-1 is a potent and selective inhibitor of MMP-13 with a IC₅₀ value of 16 nM. MMP-13-in-1 can be used for atherosclerosis research^[1].

IC₅₀ & Target^[1]

MMP13

16 nM (IC₅₀)

In Vivo

MMP-13-IN-1 (compound 5j) (2.5 mg/kg; i.v., 15 min before the use of the radiotracer) shows low uptake in metabolic organs with minimal retention of myocardial radioactivity, substantialrenal clearance, and high metabolic stability in ApoE^−/− mice models^[1].
. MMP-13-IN-1 (compound 5j) (2.5 mg/kg; i.v., 15 min before the use of the radiotracer) displays the highest overall uptake and the greatest colocalization to ORO-positive regions^[1]..

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model:	ApoE^−/− mice models^[1]
Dosage:	2.5 mg/kg
Administration:	Intravenous injection (i.v.); intravenously administered 15 min prior to the radiotracer
Result:	Blood radioactivity continued to decrease between 30 and 60 min and stabilized thereafter. Displayed a significant reduction in liver uptake. Relatively low levels of radioactivity were observed in all other measured organs except for the pancreas and spleen. Resulted in a 23% decrease in aortic plaque uptake , indicating an extent of saturable binding.

Molecular Weight

391.34

Formula

C₁₉H₁₆F₃N₃O₃

CAS No.

2925249-49-4

SMILES

FC(C(C)=C1)=CC=C1CNC(C2=NC3=C(C(N2)=O)C(OCCF)=C(C=C3)F)=O

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Purity & Documentation

Handling Instructions (2659 KB)

References

[1]. Buchler A, et al. Quinazoline-2-Carboxamides as Selective PET Radiotracers for Matrix Metalloproteinase-13 Imaging in Atherosclerosis. J Med Chem. 2023 May 25;66(10):6682-6696. [Content Brief]

MMP-13-IN-1 Related Classifications

Molarity Calculator
Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass		Concentration		Volume		Molecular Weight *
	=		×		×

The dilution calculator equation

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

This equation is commonly abbreviated as: C₁V₁ = C₂V₂

Concentration _(start)	×	Volume _(start)	=	Concentration _(final)	×	Volume _(final)
	×		=		×
C1		V1		C2		V2

Help & FAQs

Do most proteins show cross-species activity?
Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

MMP-13-IN-12925249-49-4MMPMatrix metalloproteinasesatherosclerosisApoE^?/? miceradiotracerInhibitorinhibitorinhibit

Your Recently Viewed Products:

Product Name

Salutation

Applicant Name *

Email Address *

Phone Number *

Organization Name *

Department *

Requested quantity *

Country or Region *

Remarks